Your browser doesn't support javascript.
loading
Perspectives of data science in preclinical safety assessment.
Steger-Hartmann, Thomas; Kreuchwig, Annika; Wang, Ken; Birzele, Fabian; Draganov, Dragomir; Gaudio, Stefano; Rothfuss, Andreas.
Afiliação
  • Steger-Hartmann T; Investigational Toxicology, Bayer AG, Pharmaceuticals, 13353 Berlin, Germany. Electronic address: thomas.steger-hartmann@bayer.com.
  • Kreuchwig A; Investigational Toxicology, Bayer AG, Pharmaceuticals, 13353 Berlin, Germany.
  • Wang K; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, F. Hoffmann-La-Roche AG, 4070 Basel, Switzerland.
  • Birzele F; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, F. Hoffmann-La-Roche AG, 4070 Basel, Switzerland.
  • Draganov D; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, F. Hoffmann-La-Roche AG, 4070 Basel, Switzerland.
  • Gaudio S; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, F. Hoffmann-La-Roche AG, 4070 Basel, Switzerland.
  • Rothfuss A; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, F. Hoffmann-La-Roche AG, 4070 Basel, Switzerland.
Drug Discov Today ; 28(8): 103642, 2023 08.
Article em En | MEDLINE | ID: mdl-37244565

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Software / Ciência de Dados Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Software / Ciência de Dados Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article